Table 2.
CSF Aβ42
|
CSF tau
|
CSF ptau181
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Lower* | Higher* | p | Lower | Higher | p | Lower | Higher | p | |
POMS TMD | −4.9 (−6.9 to −2.9) | −6.4 (−8.3 to −4.4) | 0.29 | −6.1 (−8.0 to −4.1) | −5.2 (−7.2 to −3.1) | 0.51 | −5.9 (−7.9 to −4.0) | −5.3 (−7.3 to −3.3) | 0.66 |
Anxiety | 33.1 (32.1 to 34.2) | 32.9 (31.9 to 34.0) | 0.80 | 32.0 (31.8 to 33.9) | 33.2 (32.2 to 34.3) | 0.64 | 32.6 (31.6 to 33.7) | 33.5 (32.4 to 34.5) | 0.27 |
Vigor | 59.7 (57.1 to 62.3) | 60.5 (57.9 to 63.0) | 0.66 | 60.3 (57.7 to 62.8) | 59.9 (57.3 to 62.5) | 0.83 | 59.9 (57.3 to 62.4) | 60.3 (57.7 to 63.0) | 0.80 |
Confusion | 38.2 (37.4 to 40.0) | 37.1 (36.3 to 37.9) | 0.06 | 37.8 (37.0 to 38.6) | 37.5 (36.7 to 38.6) | 0.62 | 37.8 (37.0 to 38.6) | 37.5 (36.7 to 38.3) | 0.57 |
CSF tau/Aβ42
|
CSF ptau/Aβ42
|
MCBP for PET PIB
|
|||||||
---|---|---|---|---|---|---|---|---|---|
Lower | Higher | p | Lower | Higher | p | Lower | Higher | p | |
POMS TMD | −5.8 (−7.8 to −3.8) | −5.5 (−7.0 to −3.5) | 0.86 | −5.9 (−7.9 to −4.0) | −5.2 (−7.3 to −3.2) | 0.63 | −6.1 (−8.1 to −4.1) | −5.0 (−7.1 to −3.0) | 0.45 |
Anxiety | 33.1 (32.1 to 34.2) | 32.8 (31.8 to 33.9) | 0.69 | 32.8 (31.7 to 33.8) | 33.4 (32.3 to 34.4) | 0.43 | 32.7 (31.7 to 33.8) | 33.5 (32.4 to 34.5) | 0.33 |
Vigor | 59.9 (57.3 to 62.5) | 60.4 (57.8 to 63.1) | 0.78 | 60.0 (57.4 to 62.5) | 60.3 (57.6 to 63.9) | 0.87 | 60.1 (57.6 to 62.7) | 60.2 (57.5 to 62.9) | 0.95 |
Confusion | 37.3 (36.5 to 38.1) | 37.9 (37.1 to 38.8) | 0.28 | 37.4 (36.6 to 38.1) | 38.0 (37.2 to 38.8) | 0.28 | 37.4 (36.6 to 38.2) | 38.1 (37.3 to 38.9) | 0.23 |
Abbreviations: POMS-SF = Profile of Mood States – Short Form; TMD = Total Mood Disturbance; Aβ42 = β-amyloid42; ptau181 = phosphorylated tau181; MCBP = Mean Cortical Binding Potential; PiB = Pittsburgh compound B.
Mean (95% Confidence Interval)